However, differences in patient populations, comparators, and selection and/or definition of secondary endpoints make it difficult to draw direct cross-trial comparisons.
It has been shown how this representation also encloses canonical configurations of corners and non-intersection endpoints, making it a powerful tool, not only for the detection of line segments but also for the extraction of such kinds of points.
"We're taking all these different devices and endpoints making it into one seamless interface [for the publisher]." Since officially announcing its platform last year, Bassolino said the company has signed up more than 1,400 customers, who manage more than 400,000 videos on the Zype platform.
The state space for different RGCs will depend upon the details of each type of genomic change, but it seems likely that the state space for microinversions is large; they can be of a variety of lengths and have any specific nucleotide for endpoints, making it unlikely that independent microinversions will appear identical.
Differences in tumor characteristics, specimens used, cohort size, techniques evaluating AR, locations of AR expression measured, and endpoints used make it very hard to compare results or to draw definitive conclusions [ 21].
A role for rituximab for this indication is supported by the consistency of the reports of improvement but differences in regimens, concomitant medications and endpoints remain, making it difficult to assess the extent of effectiveness of B-cell depletion accurately.
However, strict multiplicity control for those secondary endpoints would make it impossible to claim marginal benefit, which may discourage the investigators to collect less information and to do selective analysis.
In these "Endpoint" summaries the Top Gun technician makes it easy for himself from the mechanical angle: the forms are loose and unrhymed, held together only by the beat of the iambic pentameter.
Moreover, longitudinal monitoring also indicated a potential role for enumerating CTC as an endpoint biomarker making it possible to predict, at an early stage, whether a patient benefits or not from anticancer treatment (Hayes et al, 2006).
